rs7951

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000064.4(C3):​c.4311C>T​(p.Ala1437Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0784 in 1,613,528 control chromosomes in the GnomAD database, including 5,204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 574 hom., cov: 32)
Exomes 𝑓: 0.078 ( 4630 hom. )

Consequence

C3
NM_000064.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.297

Publications

28 publications found
Variant links:
Genes affected
C3 (HGNC:1318): (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]
C3 Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with C3 anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • complement component 3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
  • C3 glomerulonephritis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-6681980-G-A is Benign according to our data. Variant chr19-6681980-G-A is described in ClinVar as Benign. ClinVar VariationId is 330285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.297 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0928 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C3NM_000064.4 linkc.4311C>T p.Ala1437Ala synonymous_variant Exon 35 of 41 ENST00000245907.11 NP_000055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C3ENST00000245907.11 linkc.4311C>T p.Ala1437Ala synonymous_variant Exon 35 of 41 1 NM_000064.4 ENSP00000245907.4

Frequencies

GnomAD3 genomes
AF:
0.0856
AC:
13013
AN:
152100
Hom.:
568
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0947
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.0738
Gnomad ASJ
AF:
0.0936
Gnomad EAS
AF:
0.0975
Gnomad SAS
AF:
0.0960
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0768
Gnomad OTH
AF:
0.0778
GnomAD2 exomes
AF:
0.0840
AC:
21130
AN:
251496
AF XY:
0.0848
show subpopulations
Gnomad AFR exome
AF:
0.0955
Gnomad AMR exome
AF:
0.0559
Gnomad ASJ exome
AF:
0.0912
Gnomad EAS exome
AF:
0.105
Gnomad FIN exome
AF:
0.121
Gnomad NFE exome
AF:
0.0768
Gnomad OTH exome
AF:
0.0847
GnomAD4 exome
AF:
0.0777
AC:
113483
AN:
1461310
Hom.:
4630
Cov.:
31
AF XY:
0.0785
AC XY:
57079
AN XY:
727008
show subpopulations
African (AFR)
AF:
0.0928
AC:
3107
AN:
33470
American (AMR)
AF:
0.0578
AC:
2587
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0939
AC:
2453
AN:
26132
East Asian (EAS)
AF:
0.0927
AC:
3681
AN:
39696
South Asian (SAS)
AF:
0.0951
AC:
8201
AN:
86236
European-Finnish (FIN)
AF:
0.118
AC:
6326
AN:
53420
Middle Eastern (MID)
AF:
0.0839
AC:
483
AN:
5756
European-Non Finnish (NFE)
AF:
0.0735
AC:
81721
AN:
1111494
Other (OTH)
AF:
0.0815
AC:
4924
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5789
11578
17366
23155
28944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3076
6152
9228
12304
15380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0857
AC:
13051
AN:
152218
Hom.:
574
Cov.:
32
AF XY:
0.0869
AC XY:
6465
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0953
AC:
3958
AN:
41536
American (AMR)
AF:
0.0738
AC:
1128
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0936
AC:
325
AN:
3472
East Asian (EAS)
AF:
0.0970
AC:
502
AN:
5176
South Asian (SAS)
AF:
0.0961
AC:
463
AN:
4820
European-Finnish (FIN)
AF:
0.109
AC:
1157
AN:
10606
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0768
AC:
5222
AN:
68004
Other (OTH)
AF:
0.0808
AC:
171
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
615
1230
1844
2459
3074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0774
Hom.:
755
Bravo
AF:
0.0830
Asia WGS
AF:
0.0870
AC:
304
AN:
3478
EpiCase
AF:
0.0747
EpiControl
AF:
0.0757

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Age related macular degeneration 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Atypical hemolytic-uremic syndrome with C3 anomaly Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Complement component 3 deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.7
DANN
Benign
0.44
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7951; hg19: chr19-6681991; COSMIC: COSV55573596; COSMIC: COSV55573596; API